AC   CVCL_E691
SY   HAY, BD; TER301; TER-301; Ter 301; TER357; TER-357; Ter 357; TER493; TER-493; Ter-493; Ter 493
DR   dbMHC; 48887
DR   ECACC; 94082222
DR   IHW; IHW09123
DR   IPD-IMGT/HLA; 11667
DR   Wikidata; Q54881341
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*24:02:01:01; B*07:02:01,40:02:01; C*07:02:01:03,15:02:01:01; DPA1*01:03:01:02,02:02:02; DPB1*04:01:01:01,05:01:01; DQA1*01:04:01:04,01:02:01:01; DQB1*06:02:01,05:03:01; DRB1*14:07:01,15:01:01; DRB3*02:02:01,02:02:01:02; DRB5*01:01:01 (IPD-IMGT/HLA=11667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
RX   PubMed=8307784; DOI=10.1016/0198-8859(93)90514-2;
RA   Degli-Esposti M.A., Griffiths M.S.J., Daly L.N., Witt C.S., Simons M.,
RA   Carcassi C., Albert E.D., Giphart M.J., Dawkins R.L.;
RT   "Characterization of 4AOHW cell line panel including new data for the
RT   10IHW panel.";
RL   Hum. Immunol. 38:3-16(1993).